Crossref
Developing new biomarkers and treatments for breast cancer-related lymphedema.
Pathways · 2024
DOI: 10.70472/dios7434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathways, 2024. Verfasst von Jennifer Kwan.
Abstract (Originalsprache)
Dr. Jennifer Kwan MD PhD FRCPC is a Radiation Oncologist–Clinician Scientist and Assistant Professor in Radiation Oncology at the University of Toronto. Her interests include breast radiation oncology and managing side effects of cancer treatment in the Adult Radiation Late Effects Clinic at the Princess Margaret Cancer Centre.
Zitieren
APA
Kwan, J. (2024). Developing new biomarkers and treatments for breast cancer-related lymphedema. Pathways. https://doi.org/10.70472/dios7434
Vancouver
Kwan J. Developing new biomarkers and treatments for breast cancer-related lymphedema. Pathways. 2024. doi:10.70472/dios7434
BibTeX
@article{Kwan2024,
author = {Kwan, Jennifer},
title = {Developing new biomarkers and treatments for breast cancer-related lymphedema},
journal = {Pathways},
year = {2024},
doi = {10.70472/dios7434}
}
EUVIMED